(Q63354517)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11875495%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

title

CD40L stabilizes arterial thrombi by a beta3 integrin--dependent mechanism (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11875495%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11875495%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

8

Denisa D Wagner

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11875495%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

6

Richard O Hynes

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11875495%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

author name string

Patrick André

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11875495%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

Ming He

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11875495%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

K S Srinivasa Prasad

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11875495%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

Jessie M Papalia

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11875495%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

David R Phillips

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11875495%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

language of work or name

English

0 references

publication date

1 March 2002

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11875495%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11875495%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

volume

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11875495%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

page(s)

247-252

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11875495%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11875495%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/nm0302-247

7 December 2019

exact match

0 references

1 reference

https://api.crossref.org/works/10.1038%2FNM0302-247

7 January 2021

CD40 ligand on activated platelets triggers an inflammatory reaction of endothelial cells

1 reference

https://api.crossref.org/works/10.1038%2FNM0302-247

7 January 2021

Requirement for CD154 in the progression of atherosclerosis.

1 reference

https://api.crossref.org/works/10.1038%2FNM0302-247

7 January 2021

The CD40/CD154 receptor/ligand dyad

1 reference

https://api.crossref.org/works/10.1038%2FNM0302-247

7 January 2021

Biological function of CD40 on human endothelial cells: costimulation with CD40 ligand and interleukin-4 selectively induces expression of vascular cell adhesion molecule-1 and P-selectin resulting in preferential adhesion of lymphocytes

1 reference

https://api.crossref.org/works/10.1038%2FNM0302-247

7 January 2021

CD40L-CD40 interactions regulate endothelial cell surface tissue factor and thrombomodulin expression

1 reference

https://api.crossref.org/works/10.1038%2FNM0302-247

7 January 2021

The inflammatory action of CD40 ligand (CD154) expressed on activated human platelets is temporally limited by coexpressed CD40.

1 reference

https://api.crossref.org/works/10.1038%2FNM0302-247

7 January 2021

Enhanced levels of soluble and membrane-bound CD40 ligand in patients with unstable angina. Possible reflection of T lymphocyte and platelet involvement in the pathogenesis of acute coronary syndromes

1 reference

https://api.crossref.org/works/10.1038%2FNM0302-247

7 January 2021

Activation of monocyte/macrophage functions related to acute atheroma complication by ligation of CD40: induction of collagenase, stromelysin, and tissue factor.

1 reference

https://api.crossref.org/works/10.1038%2FNM0302-247

7 January 2021

Role of platelet P-selectin and CD40 ligand in the induction of monocytic tissue factor expression

1 reference

https://api.crossref.org/works/10.1038%2FNM0302-247

7 January 2021

P-selectin induces the expression of tissue factor on monocytes

1 reference

https://api.crossref.org/works/10.1038%2FNM0302-247

7 January 2021

Pro-coagulant state resulting from high levels of soluble P-selectin in blood

1 reference

https://api.crossref.org/works/10.1038%2FNM0302-247

7 January 2021

A soluble form of TRAP (CD40 ligand) is rapidly released after T cell activation

1 reference

https://api.crossref.org/works/10.1038%2FNM0302-247

7 January 2021

Thromboembolic complications after treatment with monoclonal antibody against CD40 ligand

1 reference

https://api.crossref.org/works/10.1038%2FNM0302-247

7 January 2021

A mouse model of severe von Willebrand disease: defects in hemostasis and thrombosis

1 reference

https://api.crossref.org/works/10.1038%2FNM0302-247

7 January 2021

Persistence of platelet thrombus formation in arterioles of mice lacking both von Willebrand factor and fibrinogen

1 reference

https://api.crossref.org/works/10.1038%2FNM0302-247

7 January 2021

Long-term acceptance of skin and cardiac allografts after blocking CD40 and CD28 pathways

1 reference

https://api.crossref.org/works/10.1038%2FNM0302-247

7 January 2021

Treatment with humanized monoclonal antibody against CD154 prevents acute renal allograft rejection in nonhuman primates

1 reference

https://api.crossref.org/works/10.1038%2FNM0302-247

7 January 2021

Inhibition of CD40 signaling limits evolution of established atherosclerosis in mice

1 reference

https://api.crossref.org/works/10.1038%2FNM0302-247

7 January 2021

Both early and delayed anti-CD40L antibody treatment induces a stable plaque phenotype

1 reference

https://api.crossref.org/works/10.1038%2FNM0302-247

7 January 2021

Blood-borne tissue factor: another view of thrombosis

1 reference

https://api.crossref.org/works/10.1038%2FNM0302-247

7 January 2021

New perspectives in cell adhesion: RGD and integrins

1 reference

https://api.crossref.org/works/10.1038%2FNM0302-247

7 January 2021

Ligands "activate" integrin alpha IIb beta 3 (platelet GPIIb-IIIa).

1 reference

https://api.crossref.org/works/10.1038%2FNM0302-247

7 January 2021

The immune responses in CD40-deficient mice: impaired immunoglobulin class switching and germinal center formation

1 reference

https://api.crossref.org/works/10.1038%2FNM0302-247

7 January 2021

Beta3-integrin-deficient mice are a model for Glanzmann thrombasthenia showing placental defects and reduced survival.

1 reference

https://api.crossref.org/works/10.1038%2FNM0302-247

7 January 2021

High-affinity interactions of tumor necrosis factor receptor-associated factors (TRAFs) and CD40 require TRAF trimerization and CD40 multimerization

1 reference

https://api.crossref.org/works/10.1038%2FNM0302-247

7 January 2021

Optimal antagonism of GPIIb/IIIa favors platelet adhesion by inhibiting thrombus growth. An ex vivo capillary perfusion chamber study in the guinea pig.

1 reference

https://api.crossref.org/works/10.1038%2FNM0302-247

7 January 2021

Platelet membrane defects in Glanzmann's thrombasthenia. Evidence for decreased amounts of two major glycoproteins

1 reference

https://api.crossref.org/works/10.1038%2FNM0302-247

7 January 2021